The Enterprise Value as of September 2024 (TTM) for Valneva SE (VALN) is 515.49M

According to Valneva SE’s latest financial reports and current stock price. The company's current Enterprise Value is 515.49M. This represents a change of -58.36% compared to the average of 1.24B of the last 4 quarters.

Valneva SE (VALN) Historical Enterprise Value (quarterly & annually)

How has VALN Enterprise Value performed in the past?

The mean historical Enterprise Value of Valneva SE over the last ten years is 1.98B. The current 515.49M Enterprise Value has changed 2.51% with respect to the historical average. Over the past ten years (40 quarters), VALN's Enterprise Value was at its highest in in the December 2021 quarter at 4.48B. The Enterprise Value was at its lowest in in the September 2021 quarter at 0.

Valneva SE (VALN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Valneva SE Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Valneva SE (VALN) Average Enterprise Value

How has VALN Enterprise Value performed in the past?

The current Enterprise Value of Valneva SE (VALN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Valneva SE (VALN) Enterprise Value vs. Peers

How is VALN’s Enterprise Value compared to its peers?

Valneva SE’s Enterprise Value is greater than Advaxis, Inc. (4.29M), greater than NuCana plc (-5428921.93), greater than Sage Therapeutics, Inc. (382.48M), greater than SELLAS Life Sciences Group, Inc. (69.93M), greater than Third Harmonic Bio, Inc. (353.63M), less than Cullinan Oncology, Inc. (927.81M), less than Edgewise Therapeutics, Inc. (2.73B), greater than Rallybio Corporation (29.25M), greater than Monte Rosa Therapeutics, Inc. (319.09M), less than Tyra Biosciences, Inc. (1.17B), greater than C4 Therapeutics, Inc. (450.85M), less than Stoke Therapeutics, Inc. (609.36M), less than Revolution Medicines, Inc. (7.53B), less than Opthea Limited (622.16M), greater than Inhibrx, Inc. (28.49M), less than Mineralys Therapeutics, Inc. (533.84M), greater than Eliem Therapeutics, Inc. (332.22M), greater than Anebulo Pharmaceuticals, Inc. (48.79M), less than Nuvation Bio Inc. (987.66M), greater than Instil Bio, Inc. (460.94M), greater than Connect Biopharma Holdings Limited (-41367153.00), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than Graphite Bio, Inc. (-15007658.00),

Build a custom stock screener for Valneva SE (VALN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Valneva SE using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Valneva SE (VALN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Valneva SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.